Viz.ai stock

Viz.ai Stock

HealthTech

Looking to sell Viz.ai stock or options?

Founded: 2016Funding to Date: $313Mhttps://www.viz.ai

Viz.ai develops an intelligent care coordination platform aimed at transforming global healthcare delivery. The platform utilizes advanced deep learning to promptly relay critical information about stroke patients directly to specialists for timely intervention. This technology enables healthcare providers to expedite treatment times and enhance access to care.

Investors Include:

Camford Capital, Susa Ventures, Greenoaks Capital Partners, AME Cloud Ventures, Seedcamp, Kevin Ding, Threshold Ventures, Jukka Jokinen, Halle Tecco, Scale Venture Partners, GV, CRV, Pear (California), Insight Partners (New York), DHVC, Geodesic Capital, Tiger Global Management, J Mocco, Canadian Imperial Bank of Commerce, Kleiner Perkins, Hakluyt Capital, Innovation Endeavors, Sozo Ventures, Kivu Ventures.

Collective explained in 2 minutes

Learn how Collective's solutions enable you to manage your risk and maximize your wealth

Learn more

Management Team

Manoj RamachandranCo-Founder
David GolanCo-Founder & Board Member
Julie SkaffChief Operating Officer
David KiznerChief Privacy Officer & General Counsel
Jieun ChoeChief Marketing Officer
Christopher Mansi MDCo-Founder, Chief Executive Officer & Board Member
Thomas KrohnGlobal Pharma Commercial Lead
Jacob SchiftanHead of Product
William StadtlanderVice President, Global Med Tech Commercial Lead
Steve SweenyVice President, Business Development and Strategy
Anne HellieSenior Director of Strategic Engagement
Eric LubbersVice President Provider Sales
Nina BinettiVice President of Marketing
Michael HerringChief Financial Officer

Board Members

Neil ShahBoard Member
Mamoon HamidBoard Member
Rory O'DriscollBoard Member
Kevin DingBoard Member

Viz.ai’s stock FAQs

Other HealthTech Companies in Collective's late-stage Target Portfolio.

Abridge stock
Benchling stock
Devoted Health stock
Maven Clinic stock
Modern Health stock
Rightway stock
Spring Health stock
SWORD Health stock
Zocdoc stock

Companies backed by the same VC's

Chainguard stock
Chronosphere stock
Databricks stock
Dexterity stock
Flock Safety stock
Glean stock
Gusto stock
Harvey stock
Intercom stock
Mashgin stock
Modern Health stock
Motive stock
Persona stock
SpaceX stock
Together stock

Viz.ai in the News

Source: Financial TimesViz.ai Wins 2025 Edison Award™ for Machine Learning Innovation for the Third Consecutive Year

The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting rights, and directors and dealings.

Read more
Source: Financial ContentViz.ai Integrates Avicenna.AI's Tools for ASPECTS Stroke Severity Assessment and Incidental Pulmonary Embolism into Viz.ai One P...

Viz.ai Integrates Avicenna.AI's Tools for ASPECTS Stroke Severity Assessment and Incidental Pulmonary Embolism into Viz.ai One Platform

Read more
Source: Market ScreenerViz.ai to Participate in Morgan Stanley 22nd Annual Healthcare Conference

SAN FRANCISCO - Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced Chris Mansi, MD, CEO and Co-founder, will present at the Morgan Stanley 22nd...

Read more
Source: 01netViz.ai and Medtronic Collaborate to Improve Post-Acute Stroke Patient Care in the United States

Collaboration aims to help cryptogenic stroke patients receive necessary cardiology follow-up to reduce risk of secondary strokeSAN FRANCISCO--(BUSINESS

Read more
Source: 01netViz.ai Receives FDA 510(k) Clearance for Artificial Intelligence Algorithm for the Quantification of Intracerebral Hemorrhage

New AI algorithm enables precise and reliable quantification of intracerebral hemorrhage to make accurate and timely treatment decisionsSAN

Read more
Source: Medical Device NetworkViz.ai’s aneurysm diagnostic tool is 97.2% predictive in ruling out stroke

The AI-powered diagnostic platform can diagnose the presence of aneurysms by analysing computed tomography (CT) scans.

Read more
Source: ForbesHow Viz.ai Uses Artificial Intelligence To Treat Stroke Patients Faster

The startup has 12 FDA-approved algorithms, agreements with more than 1,500 U.S. hospitals, and plans to work with drug companies to reduce healthcare roadblocks.

Read more
Source: Business WireViz.ai Launches AI-Powered Viz™ Vascular Suite

SAN FRANCISCO--(BUSINESS WIRE)-- #ai--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the launch of VizTM Vascular Suite, AI-powered software enabling vascular care teams to automatically detect and triage…

Read more
Source: Business WireViz.ai Wins Four Comparably Awards for Best Place to Work

SAN FRANCISCO--(BUSINESS WIRE)-- #ai--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, has received two additional Comparably Best Place to Work Awards for Best Company Culture and Best Company for Diversity in 2022. Earli…

Read more
Source: Business WireViz.ai and Cercare Medical Partner to Support Neurovascular Clinical DecisionMaking

SAN FRANCISCO--(BUSINESS WIRE)-- #ai--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a partnership with Cercare Medical, which delivers next-level medical imaging with CT and MRI. The partnership will inc…

Read more